Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 305

1.

Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma.

Sviggum HP, Davis MD, Rajkumar SV, Dispenzieri A.

Arch Dermatol. 2006 Oct;142(10):1298-302.

PMID:
17043184
[PubMed - indexed for MEDLINE]
2.

Dermatologic side effects of thalidomide in patients with multiple myeloma.

Hall VC, El-Azhary RA, Bouwhuis S, Rajkumar SV.

J Am Acad Dermatol. 2003 Apr;48(4):548-52.

PMID:
12664018
[PubMed - indexed for MEDLINE]
3.

Lenalidomide: new drug. Myeloma: many questions remain unanswered.

[No authors listed]

Prescrire Int. 2008 Dec;17(98):230-2.

PMID:
19422142
[PubMed - indexed for MEDLINE]
4.

Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure.

Wang M, Dimopoulos MA, Chen C, Cibeira MT, Attal M, Spencer A, Rajkumar SV, Yu Z, Olesnyckyj M, Zeldis JB, Knight RD, Weber DM.

Blood. 2008 Dec 1;112(12):4445-51. doi: 10.1182/blood-2008-02-141614. Epub 2008 Sep 17.

PMID:
18799726
[PubMed - indexed for MEDLINE]
Free Article
5.

Lenalidomide and venous thrombosis in multiple myeloma.

Rajkumar SV, Blood E.

N Engl J Med. 2006 May 11;354(19):2079-80. No abstract available.

PMID:
16696148
[PubMed - indexed for MEDLINE]
6.

United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myeloma.

Davies F, Morris C, Bird J, Cook G, Williams C, Tighe J, Cavenagh J, Behrens J, Schey S, Morgan G; United Kingdom Myeloma Forum.

Int J Lab Hematol. 2009 Apr;31(2):119-31. doi: 10.1111/j.1751-553X.2008.01106.x. Epub 2008 Nov 4. Review.

PMID:
19016917
[PubMed - indexed for MEDLINE]
7.

Lenalidomide in the treatment of multiple myeloma: a review.

Armoiry X, Aulagner G, Facon T.

J Clin Pharm Ther. 2008 Jun;33(3):219-26. doi: 10.1111/j.1365-2710.2008.00920.x. Review.

PMID:
18452408
[PubMed - indexed for MEDLINE]
8.

[The use of lenalidomide in the treatment of multiple myeloma].

Holánek M, Hájek R.

Klin Onkol. 2010;23(2):67-72. Review. Czech.

PMID:
20465083
[PubMed - indexed for MEDLINE]
9.

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.

Dispenzieri A, Lacy MQ, Zeldenrust SR, Hayman SR, Kumar SK, Geyer SM, Lust JA, Allred JB, Witzig TE, Rajkumar SV, Greipp PR, Russell SJ, Kabat B, Gertz MA.

Blood. 2007 Jan 15;109(2):465-70. Epub 2006 Sep 28.

PMID:
17008538
[PubMed - indexed for MEDLINE]
Free Article
10.

Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide.

Mariz JM, Esteves GV.

Curr Opin Oncol. 2012 Jan;24 Suppl 2:S3-11. doi: 10.1097/01.cco.0000410243.84074.dc. Review.

PMID:
22245806
[PubMed - indexed for MEDLINE]
11.

Lenalidomide and its role in the management of multiple myeloma.

Falco P, Cavallo F, Larocca A, Liberati AM, Musto P, Boccadoro M, Palumbo A.

Expert Rev Anticancer Ther. 2008 Jun;8(6):865-74. doi: 10.1586/14737140.8.6.865. Review.

PMID:
18533796
[PubMed - indexed for MEDLINE]
12.

Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.

Palumbo A, Dimopoulos M, San Miguel J, Harousseau JL, Attal M, Hussein M, Knop S, Ludwig H, von Lilienfeld-Toal M, Sonneveld P.

Blood Rev. 2009 Mar;23(2):87-93. doi: 10.1016/j.blre.2008.07.003. Epub 2008 Sep 6. Review.

PMID:
18774632
[PubMed - indexed for MEDLINE]
13.

Lenalidomide in myelodysplastic syndrome and multiple myeloma.

Shah SR, Tran TM.

Drugs. 2007;67(13):1869-81. Review.

PMID:
17722955
[PubMed - indexed for MEDLINE]
14.

Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.

Hazarika M, Rock E, Williams G, Dagher R, Sridhara R, Booth B, Farrell A, Justice R, Pazdur R.

Oncologist. 2008 Oct;13(10):1120-7. doi: 10.1634/theoncologist.2008-0077. Epub 2008 Oct 15.

PMID:
18922829
[PubMed - indexed for MEDLINE]
Free Article
15.

Lenalidomide in the treatment of multiple myeloma.

Rao KV.

Am J Health Syst Pharm. 2007 Sep 1;64(17):1799-807. Review.

PMID:
17724360
[PubMed - indexed for MEDLINE]
16.

Lenalidomide in multiple myeloma.

Thomas SK, Richards TA, Weber DM.

Best Pract Res Clin Haematol. 2007 Dec;20(4):717-35. Review.

PMID:
18070715
[PubMed - indexed for MEDLINE]
17.

Lenalidomide: an update on evidence from clinical trials.

Dimopoulos MA, Terpos E.

Blood Rev. 2010 Nov;24 Suppl 1:S21-6. doi: 10.1016/S0268-960X(10)70005-9.

PMID:
21126633
[PubMed - indexed for MEDLINE]
18.

Lenalidomide and venous thrombosis in multiple myeloma.

Knight R, DeLap RJ, Zeldis JB.

N Engl J Med. 2006 May 11;354(19):2079-80. No abstract available.

PMID:
16687729
[PubMed - indexed for MEDLINE]
Free Article
19.

Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.

Niesvizky R, Martínez-Baños D, Jalbrzikowski J, Christos P, Furst J, De Sancho M, Mark T, Pearse R, Mazumdar M, Zafar F, Pekle K, Leonard J, Jayabalan D, Coleman M.

Leuk Lymphoma. 2007 Dec;48(12):2330-7.

PMID:
18067007
[PubMed - indexed for MEDLINE]
20.

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial.

Sanchorawala V, Wright DG, Rosenzweig M, Finn KT, Fennessey S, Zeldis JB, Skinner M, Seldin DC.

Blood. 2007 Jan 15;109(2):492-6. Epub 2006 Sep 7.

PMID:
16960148
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk